Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04484675
PHASE4

Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension

Sponsor: Zagazig University

View on ClinicalTrials.gov

Summary

The investigator compared difference between inhaled and intravenous milirinone in patiens with severe pulmonary hypertension undergoing cardiac surgery

Official title: Comparative Study Between Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension Undergoing Cardiac Surgery

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

38

Start Date

2023-05-20

Completion Date

2025-05-10

Last Updated

2025-04-30

Healthy Volunteers

No

Interventions

DRUG

Milrinone inhalation

After induction of anesthesia and stable hemodynamics inhaled milrinone( 1 mg/ml) is initiated and intravenous placebo ( normal saline )infusion are administered

DRUG

Milrinone infusion

After induction of anesthesia and stable hemodynamics inhaled placebo( normal saline) is initiated and intravenous ( 1 mg/ml) (0.5 μg/kg/min)infusion are administered

Locations (1)

Zagazig University

Zagazig, Sharqia Province, Egypt